Navigation Links
Joint Implant Surgeons Join Major Clinical Study to Transform the Knee and Hip Replacement Experience with Apple Watch® and iPhone® Technology

Joint Implant Surgeons (JIS), a world leader in outpatient joint replacements and the premier orthopedic institution in the Midwest, is one of only nine group practice centers in the nation to be selected to participate in the Zimmer Biomet mymobility™ Clinical Study. Two of the most common surgeries Americans undergo each year—knee and hip replacement—will be transformed by the Zimmer Biomet mymobility app, which uses Apple Watch technology to connect patients and their surgical teams. The nation-wide research is one of the largest evidence-gathering clinical studies in orthopedic history. The study, launched the week of Oct. 15, 2018, has the potential to enroll as many as 10,000 participants.

The Zimmer Biomet study is designed to assess the impact on patient outcomes and overall costs for joint replacements. Patients will use Zimmer Biomet mymobility with Apple Watch, and researchers will combine patient-reported feedback with continuous health and activity data. The data gathered will be used to guide patients through pre- and post-op care.

“We are excited to join only 17 other sites in the country to be a part of the Zimmer Biomet study, as we detail the patient experience through this innovative approach to data collection," said Dr. Keith Berend of JIS. “We are confident that, through this research, we will gain new insights that will impact the standard of care for knee and hip replacement patients.”

Patients will be provided with virtual support and guidance throughout the joint replacement journey, and physicians will receive continuous data to optimize care. The app has several features that use both Apple Watch and iPhone, including the ability for surgeons to send education and therapy reminders directly to the patient’s Apple Watch. The app also allows monitoring of patient activity levels throughout the days and weeks they are preparing for, and then recovering from, surgery.

Adult patients who are scheduled for a total or partial knee replacement or total hip replacement at an approved clinical study site are eligible to participate. They must have an iPhone 6 or later, and be scheduled to receive a Zimmer Biomet knee or hip device as part of their clinical care. Other inclusion criteria include a diagnosis of osteoarthritis.

To learn more about the mymobility clinical study, visit

Apple Watch and iPhone are registered trademarks of Apple, Inc. mymobility is a trademark of Zimmer Biomet or one of its subsidiaries.

TWEET THIS: Joint Implant Surgeons selected as the only orthopedic practice in Ohio to participate in the Zimmer Biomet mymobility Clinical Study

About Joint Implant Surgeons
Joint Implant Surgeons is a team of world-renowned physicians dedicated to positive patient outcomes, musculoskeletal innovation, and setting the global standard for orthopedic care revolutionizing the orthopedic field.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related medicine technology :

1. Zyga Releases 24-month CT Fusion and Clinical Results for SImmetry SI Joint Fusion with Decortication
2. Dr. William Cross III to Present 24-month Fusion and Clinical Results of Sacroiliac Joint Fusion with Decortication
3. SI-BONE, Inc. Announces Published Guidance Recommendation for Minimally Invasive SI Joint Fusion from the National Institute for Health and Care Excellence (NICE)
4. North American Cannabis Holdings and Puration Schedule Joint Online Presentation to Review $2 Million and $5 Million Forecast Progress and Next Dividends
5. SI-BONE, Inc. Launches SI Joint Womens Health Initiative at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego, March 14 - 17
6. Joint Venture Between Lumichip and NEUTEX Lighting
7. Tempus And University Hospitals Seidman Cancer Center Announce Joint Effort To Customize Treatment For Cancer Patients
8. Rosa & Co. and MathWorks Host Joint Webinar Discussion on How MATLAB and SimBiology Facilitate Quantitative Systems Pharmacology (QSP) Modeling and Analysis to Support Drug Development
9. A Subsidiary of Rostec Corporation and HTC ChemRar Launch a Joint Venture for Development and Manufacturing of the Next Generation of Antivirals in Russia and the Eurasian Economic Union
10. Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss
11. Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
Post Your Comments:
(Date:2/14/2019)... ... February 14, 2019 , ... San ... UroLift® Center of Excellence. The designation recognizes that Dr. Peterson has achieved a ... commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic ...
(Date:2/13/2019)... ... February 14, 2019 , ... Entomol’s ... approval by the California EPA for release and sale within the state. California ... major milestone in Entomol‘s commercial development. This registration opens the door for wholesale/retail ...
(Date:2/13/2019)... ... 13, 2019 , ... NCPDP announced today that Jim Carroll, ... Wednesday, May 8, at its 2019 Annual Technology & Business Conference. Themed Dare ... Spa in Scottsdale, Arizona, and is expected to draw more than 700 attendees ...
Breaking Medicine Technology:
(Date:2/13/2019)... ... 2019 , ... Diameter Health , the leader in clinical data normalization ... Management Act (FISMA) High General Support System Authority to Operate (ATO) for Diameter Health’s ... for the VA because of their work with confidential patient data. Protecting this data ...
(Date:2/13/2019)... ... ... Castle announced today that it has raised $9.2M in Series A funding from ... First Round and F-Prime Capital Partners . Angel investors joining the round ... Networks, and Olivier Pomel, CEO at Datadog. This round brings the company’s total funding ...
(Date:2/13/2019)... ... 13, 2019 , ... American Vision Partners, one of the ... a new addition to their growing list of ophthalmology brands: Visage Aesthetics & ... ophthalmology practice. , Dr. Zachary Berbos, MD, FACS, and Dr. Grant ...
(Date:2/13/2019)... ... ... A Place at Home has received the 2019 Best of ... Choice Award is granted only to the top-ranking home care providers, based on caregiver ... care. A Place at Home is ranked among the best employers of in-home caregivers ...
(Date:2/13/2019)... ... 2019 , ... Surgery that moves both jaws forward – known as maxillomandibular ... (OSA), resulting in benefits that include improved breathing, daytime wakefulness and quality of life, ... should be regarded as the preferred treatment for patients with moderate to severe OSA ...
Breaking Medicine News(10 mins):